Advances in Prostaglandin

Prostaglandins (PG) are a group of physiologically active lipid compounds called eicosanoids having diverse hormone-like effects in animals. Prostaglandins have been found in almost every tissue in humans and other animals. They are derived enzymatically from the fatty acid arachidonic acid.Every prostaglandin contains 20 carbon atoms, including a 5-carbon ring. They are a subclass of eicosanoids and of the prostanoid class of fatty acid derivatives.

In the present book, twelve typical literatures about prostaglandin published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on prostaglandin. We hope this book can demonstrate advances in prostaglandin as well as give references to the researchers, students and other related people.

Sample Chapter(s)
preface (96 KB)
Components of the Book:
  • Chapter 1
    In situ imaging reveals disparity between prostaglandin localization and abundance of prostaglandin synthases
  • Chapter 2
    The inhibitory effect of AMP-activated protein kinase (AMPK) on chemokine and prostaglandin production in human endometrial stromal cells
  • Chapter 3
    Ageing influences detrusor contractions to prostaglandin, angiotensin, histamine and 5‑HT (serotonin), independent to the Rho kinase and extracellular calcium pathways
  • Chapter 4
    Predictive Value of Dynamic Corneal Response Parameters Evaluated with Scheimpflug High-Speed Video (Corvis ST) on the Visual Field Progression in Prostaglandin Treated Ocular Hypertension and Open-Angle Glaucoma Patients
  • Chapter 5
    Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4
  • Chapter 6
    Comparison between Prostaglandin E‑major urinary metabolite and C‑reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis
  • Chapter 7
    Association of urinary prostaglandin E2 metabolite and mortality among adults
  • Chapter 8
    Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
  • Chapter 9
    The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15mmHg and Under: ROCK U-15
  • Chapter 10
    Prostaglandin E2 stimulates COX-2 expression via mitogen-activated protein kinase p38 but not ERK in human follicular dendritic cell-like cells
  • Chapter 11
    Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study
  • Chapter 12
    Innovative therapeutic strategy using prostaglandin I2 agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension
Readership: Students, academics, teachers and other people attending or interested in Prostaglandin.
Kyle D. Duncan
Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden

Yasushi Kawano
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Charlotte Phelps
Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD 4226,Australia

Marta I. Martinez-Sa´nchez
Hospital Universitario ‘‘Principe de Asturias’’, Alcala′de Henares, Madrid, Spain

Takayasu Kanno
Department of Pharmacology, Asahikawa Medical University, Asahikawa, Japan

Natsuki Ishida
First Department of Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu-shi,Higashi-ku, Shizuoka 431-3192, Japan

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top